Abstract
Heat shock protein 27 (HSP27), an intracellular molecular chaperone, is involved in the pathogenesis of cancer by promoting both tumor cell proliferation and resistance to therapy. HSP27 is also present in the circulation and circulating HSP27 (sHSP27) can elicit an autoimmune response with production of antibodies. Levels of sHSP27 are enhanced in patients with hepatocellular carcinoma (HCC); it is, however, unknown whether changes in HSP27 antibody levels occur in patients with HCC and can be exploited as a circulating biomarker of HCC. Our aim was to assess the potential association between newly diagnosed HCC and serum anti-HSP27 antibody levels. In this cross-sectional study, anti-HSP27 antibody levels were measured in serum samples from 71 HCC patients, 80 subjects with chronic liver disease, and 38 control subjects by immunoenzymatic assay. Anti-HSP27 antibody levels did not differ significantly among groups. However, in patients with chronic active hepatitis/cirrhosis, anti-HSP27 levels were significantly higher in subjects with a positive history of alcoholism (p = 0.03). Our data do not support the hypothesis that anti-HSP27 antibody levels may help identify patients with HCC among subjects with chronic liver disease. However, our finding that alcohol-related liver disease is associated with higher anti-HSP27 levels is novel and deserves further investigations.
Similar content being viewed by others
References
Akada J, Kamei S, Ito A, Ito M, Kitagawa T, Furumoto H, Kato Y, Tamesa M, Takashima M, Shirai M, Yamano H, Oka M, Kuramitsu Y, Nakamura K (2013) A new type of protein chip to detect hepatocellular carcinoma-related autoimmune antibodies in the sera of hepatitis C virus-positive patients. Proteome Sci 11:33. https://doi.org/10.1186/1477-5956-11-33
American Liver Tumor Study Group (1998) A randomized prospective multi-institutional trial of orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma. United Network for Organ Sharing, Virginia
Bahrami A, Khorasanchi Z, Tayefi M, Avan A, Seifi N, Tavakoly Sany SB, Ferns GA, Bahrami-Taghanaki H, Ghayour-Mobarhan M (2019) Anemia is associated with cognitive impairment in adolescent girls: a cross-sectional survey. Appl Neuropsychol Child 20:1–7. https://doi.org/10.1080/21622965.2018.1550405
Banerjee S, Lin CFL, Skinner KA, Schiffhauer LM, Peacock J, Hicks DG, Redmond EM, Morrow D, Huston A, Shayne M, Langstein HN, Miller-Graziano CL, Strickland J, O'Donoghue L, De AK (2011) Heat shock protein 27 differentiates tolerogenic macrophages that may support human breast cancer progression. Cancer Res 71:318–327. https://doi.org/10.1158/0008-5472.CAN-10-1778
Batulan Z, Pulakazhi Venu VK, Li Y, Koumbadinga G, Alvarez-Olmedo DG, Shi C, O’Brien ER (2016) Extracellular release and signaling by heat shock protein 27: role in modifying vascular inflammation. Front Immunol 7:285. https://doi.org/10.3389/fimmu.2016.00285
Burt D, Bruno G, Chaturvedi N, Schalkwijk, Stehouwer CD, Witte DR, Fuller JH, Pinach S, Cavallo Perin P, Gruden G (2009) Anti-heat shock protein 27 antibody levels and diabetes complications in the EURODIAB study. Diabetes Care 32:1269–1271. https://doi.org/10.2337/dc08-2271
Chen Y, Shi C, Deng J, Diao C, Maarouf N, Rosin M, Shrivastava V, Hu AA, Bharadwa S, Adijiang A, Ulke-Lemee A, Gwilym B, Hellmich A, Malozzi C, Batulan Z, Dean JLE, Ramirez FD, Liu J, Gerthoffer WT, O’Brien ER (2020) Heat shock protein 27 immune complex upregulates LDLR expression thereby reducing plasma cholesterol and atherogenesis. bioRxiv:2020.2005.2021.102350. https://doi.org/10.1101/2020.05.21.102350
Choi SK, Kam H, Kim KY, Park SI, Lee YS (2019) Targeting heat shock protein 27 in cancer: a druggable target for cancer treatment? Cancers 11:1195. https://doi.org/10.3390/cancers11081195
Conroy SC, Sasieni PD, Amin V, Wang DY, Smith P, Fentiman IS, Latchman DS (1998) Antibodies to heat-shock protein 27 are associated with improved survival in patients with breast cancer. Br J Cancer 77:1875–1879. https://doi.org/10.1038/bjc.1998.312
Feng JT, Liu YK, Song HY, Dai Z, Qin LX, Almofti RM, Fang CY, Lu HJ, Yang PY, Tang ZY (2005) Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 5:4581–4588. https://doi.org/10.1002/pmic.200401309
Gruden G, Carucci P, Lolli V, Cosso L, Dellavalle E, Rolle E, Cantamessa A, Pinach S, Abate ML, Campra D, Brunello F, Bruno G, Rizzetto M, Cavallo Perin P (2013) Serum heat shock protein 27 levels in patients with hepatocellular carcinoma. Cell Stress Chaperones 18:235–241. https://doi.org/10.1007/s12192-012-0377-8
Guo H, Bai Y, Xu P, Hu Z, Liu L, Wang F, Jin G, Wang F, Deng Q, Tu Y, Feng M, Lu D, Shen H, Wu T (2010) Functional promoter-1271G> C variant of HSPB1 predicts lung cancer risk and survival. J Clin Oncol 28:1928–1935. https://doi.org/10.1200/JCO.2009.24.4954
Homaei-Shandiz F, Mehrad-Majd H, Tasbandi M, Aledavood A, Tavakol Afshari J, Ghavami V, Ghayour-Mobarhan M (2016) Anti-heat shock protein-27 antibody levels in women with breast cancer: association with disease complications and two-year disease-free survival. Asian Pac J Cancer Prev 17:4655–4659. https://doi.org/10.22034/apjcp.2016.17.10.4655
Jones LB, Kumar S, Curry AJ, Price JS, Krendelchtchikov A, Crenshaw BJ, Bell CR, Williams SD, Tolliver TA, Saldanha SN, Sims B, Matthews QL (2019) Alcohol exposure impacts the composition of HeLa-derived extracellular vesicles. Biomedicines 7:78. https://doi.org/10.3390/biomedicines7040078
Kargari M, Tavassoli S, Avan A, Ebrahimi M, Azarpazhooh MR, Asoodeh R, Nematy M, Hassanian SM, Rahmani F, Mohammadzade E, Esmaeili H, Moohebati M, Fernsh GA, Ghayour-Mobarhan M, Parizadeh SMR (2017) Relationship between serum anti-heat shock protein 27 antibody levels and obesity. Clin Biochem 50:690–695. https://doi.org/10.1016/j.clinbiochem.2017.02.015
Li L, Chen SH, Yu CH, Li YM, Wang SQ (2008) Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray. J Proteome Res 7:611–620. https://doi.org/10.1021/pr070525r
Li SQ, Wang P, Wang DM, Lu HJ, Li RF, Duan LX, Zhu S, Wang SL, Zhang YY, Wang YL (2019) Molecular mechanism for the influence of gender dimorphism on alcoholic liver injury in mice. Hum Exp Toxicol 38:65–81. https://doi.org/10.1177/0960327118777869
Liang C, Xu Y, Ge H, Li G, Wu J (2018) The clinicopathological and prognostic value of HSP27 in hepatocellular carcinoma: a systematic review and meta-analysis. Onco Targets Ther 11:1293–1303. https://doi.org/10.2147/OTT.S154227
Looi KS, Nakayasu ES, Diaz RA, Tan EM, Almeida IC, Zhang JY (2008) Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. J Proteome Res 7:4004–4012. https://doi.org/10.1021/pr800273h
Navarro-Zaragoza J, Ros-J Proteome Res Simó C, Milanés MV, Valverde O, Laorden ML (2019) Binge ethanol and MDMA combination exacerbates HSP27 and Trx-1 (biomarkers of toxic cardiac effects) expression in right ventricle. Life Sci 220:50–57. https://doi.org/10.1016/j.lfs.2019.01.050
Olejek A, Damasiewicz-Bodzek A, Bodzek P, Wielkoszyński T, Zamłyński J, Stołtny P, Skutil M (2009) Concentrations of antibodies against heat shock protein 27 in the sera of women with ovarian carcinoma. Int J Gynecol Cancer 19:1516–1520. https://doi.org/10.1111/IGC.0b013e3181bf425b
Saha B, Momen-Heravi F, Furi I, Kodys K, Catalano D, Gangopadhyay A, Haraszti R, Satishchandran A, Iracheta-Vellve A, Adejumo A, Shaffer SA, Szabo G (2018) Extracellular vesicles from mice with alcoholic liver disease carry a distinct protein cargo and induce macrophage activation through heat shock protein 90. Hepatology 67:1986–2000. https://doi.org/10.1002/hep.29732
Shabangu CS, Huang JF, Hsiao HH, Yu ML, Chuang WL, Wang SC (2020) Liquid biopsy for the diagnosis of viral hepatitis, fatty liver steatosis, and alcoholic liver diseases. Int J Mol Sci 21:3732. https://doi.org/10.3390/ijms21103732
Shi C, Chen Y, Li Y, O’Brien ER (2014) When auto-antibodies potentiate: the paradoxical signalling role of anti-Hsp27 auto-antibody immune complexes improves athero-protection. Circulation 130(Suppl 2):A12771
Shi C, Ulke-Lemée A, Deng J, Batulan Z, O'Brien ER (2019) Characterization of heat shock protein 27 in extracellular vesicles: a potential anti-inflammatory therapy. FASEBJ 33:1617–1630. https://doi.org/10.1096/fj.201800987R
Shi C, Deng J, Chiu M, Chen XY, O’Brien ER (2020) Heat shock protein 27 immune complex altered signaling and transport (ICAST): novel mechanisms of attenuating inflammation. bioRxiv https://doi.org/10.1101/2020.05.31.126581
Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Harada T, Fujimoto M, Sakaida I, Okita K, Oka M, Nakamura K (2006) Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Proteomics 6:3894–3900. https://doi.org/10.1002/pmic.200500346
Thuringer D, Jego G, Wettstein G, Terrier O, Cronier L, Yousfi N, Hébrard S, Bouchot A, Hazoumé A, Joly AL, Gleave M, Rosa-Calatrava M, Solary E, Garrido C (2013) Extracellular HSP27 mediates angiogenesis through Toll-like receptor 3. FASEBJ 27:4169–4183. https://doi.org/10.1096/fj.12-226977
Toth ME, Gonda S, Vigh L, Santha M (2010) Neuroprotective effect of small heat shock protein, Hsp27, after acute and chronic alcohol administration. Cell Stress Chaperones 15:807–817. https://doi.org/10.1007/s12192-010-0188-8
Wang C, Zhang Y, Guo K, Wang N, Jin H, Liu Y, Qin W (2016) Heat shock proteins in hepatocellular carcinoma: molecular mechanism and therapeutic potential. Int J Cancer 138:1824–1834. https://doi.org/10.1002/ijc.29723
Welsh MJ, Gaestel M (1998) Small heat-shock protein family: function in health and disease. Ann N Y Acad Sci 851:28–35. https://doi.org/10.1111/j.1749-6632.1998.tb08973.x
Xu J (2018) Trends in liver cancer mortality among adults aged 25 and over in the United States, 2000–2016. National Center for Health Statistics, Hyattsville
Zborek A, Malusecka E, Rusin A, Krzyzowska-Gruca S, Krawczyk Z (2006) Influx of macrophages into livers of rats treated with hepatotoxicants (thioacetamide, allyl alcohol, d-galactosamine) induces expression of HSP25. J Mol Histol 37:381–389. https://doi.org/10.1007/s10735-006-9068-z
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gruden, G., Carucci, P., Barutta, F. et al. Serum levels of anti-heat shock protein 27 antibodies in patients with chronic liver disease. Cell Stress and Chaperones 26, 151–157 (2021). https://doi.org/10.1007/s12192-020-01164-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12192-020-01164-3